Your browser doesn't support javascript.
loading
Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma.
Theurich, Sebastian; Rothschild, Sacha I; Hoffmann, Michael; Fabri, Mario; Sommer, Andrea; Garcia-Marquez, Maria; Thelen, Martin; Schill, Catherine; Merki, Ramona; Schmid, Thomas; Koeberle, Dieter; Zippelius, Alfred; Baues, Christian; Mauch, Cornelia; Tigges, Christian; Kreuter, Alexander; Borggrefe, Jan; von Bergwelt-Baildon, Michael; Schlaak, Max.
Afiliação
  • Theurich S; Department I of Internal Medicine, Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Cologne Interventional Immunology, Department I of Internal Medicine, University Hospital of Cologne, Germany. Max-Planck-Institute for Metabolism Research, Cologne, Germany. Ra
  • Rothschild SI; Cologne Interventional Immunology, Department I of Internal Medicine, University Hospital of Cologne, Germany. University Hospital Basel, Department of Internal Medicine, Medical Oncology, Basel, Switzerland.
  • Hoffmann M; Department of Dermatology/Venereology and Skin-Cancer-Center at the CIO, University Hospital of Cologne, Cologne, Germany.
  • Fabri M; Department of Dermatology/Venereology and Skin-Cancer-Center at the CIO, University Hospital of Cologne, Cologne, Germany.
  • Sommer A; Department of Dermatology/Venereology and Skin-Cancer-Center at the CIO, University Hospital of Cologne, Cologne, Germany.
  • Garcia-Marquez M; Cologne Interventional Immunology, Department I of Internal Medicine, University Hospital of Cologne, Germany.
  • Thelen M; Cologne Interventional Immunology, Department I of Internal Medicine, University Hospital of Cologne, Germany.
  • Schill C; Division of Hematology/Oncology, Cantonal Hospital of Aarau, Aarau, Switzerland.
  • Merki R; Division of Hematology/Oncology, Cantonal Hospital of Aarau, Aarau, Switzerland.
  • Schmid T; Medical Oncology, St. Claraspital, Basel, Switzerland.
  • Koeberle D; Medical Oncology, St. Claraspital, Basel, Switzerland.
  • Zippelius A; University Hospital Basel, Department of Internal Medicine, Medical Oncology, Basel, Switzerland.
  • Baues C; Radio-Immuno-Oncology (RIO) Initiative, University Hospital of Cologne, Cologne, Germany. Department of Radiation Therapy, University Hospital of Cologne, Cologne, Germany.
  • Mauch C; Department of Dermatology/Venereology and Skin-Cancer-Center at the CIO, University Hospital of Cologne, Cologne, Germany.
  • Tigges C; Helios-Klinik St. Elisabeth, Department of Dermatology, Oberhausen, Germany.
  • Kreuter A; Helios-Klinik St. Elisabeth, Department of Dermatology, Oberhausen, Germany.
  • Borggrefe J; Institute for Diagnostic and Interventional Radiology, University Hospital of Cologne, Cologne, Germany.
  • von Bergwelt-Baildon M; Department I of Internal Medicine, Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Cologne Interventional Immunology, Department I of Internal Medicine, University Hospital of Cologne, Germany. Radio-Immuno-Oncology (RIO) Initiative, University Hospital of Col
  • Schlaak M; Radio-Immuno-Oncology (RIO) Initiative, University Hospital of Cologne, Cologne, Germany. Department of Dermatology/Venereology and Skin-Cancer-Center at the CIO, University Hospital of Cologne, Cologne, Germany.
Cancer Immunol Res ; 4(9): 744-54, 2016 09 02.
Article em En | MEDLINE | ID: mdl-27466265

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ipilimumab / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ipilimumab / Antineoplásicos Imunológicos / Melanoma Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article